IQVIA
IQVIA Holdings Inc. (NYSE: IQV) provides clinical research services, commercial insights and healthcare intelligence to life sciences and healthcare organizations. Its offerings support drug development and commercialization through clinical trial design and operations, laboratory services, real-world evidence,… From the company’s description.
In fiscal 2025, IQVIA reported revenue of $16.31B, up 5.9% from fiscal 2024, and net income of $1.36B. Its operating margin was 13.4%, and operations generated $2.65B in cash. Over the twelve months to Jun 30, 2026, revenue was $16.98B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What IQVIA does
In the company’s own words
IQVIA Holdings Inc. (NYSE: IQV) provides clinical research services, commercial insights and healthcare intelligence to life sciences and healthcare organizations. Its offerings support drug development and commercialization through clinical trial design and operations, laboratory services, real-world evidence, healthcare data and analytics, cloud-based software, consulting, contract sales and medical services, and patient engagement. Customers include pharmaceutical, biotechnology, medical device and diagnostic companies, as well as providers, payers, government agencies, distributors and pharmacies. IQVIA has three reportable segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions; effective January 1, 2026, its segment structure comprises Commercial Solutions and Research & Development Solutions. Its technology platforms include the MIDAS, Analytics Link and Disease Insights information offerings, while Avacare Clinical Research Network supports clinical studies through investigators and research locations. IQVIA’s data resources include more than 1.2 billion longitudinal, non-identified patient records. In 2025, the company serves more than 10,000 clients across over 100 countries. Its website is https://www.iqvia.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Professional Services
- Headquarters
- DURHAM, NC
- Fiscal year end
- December
- CIK
- 1478242
- SIC
- 8731
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns IQVIA — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in IQVIA · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · IQVIA’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
IQVIA’s bonds, as funds hold them
Funds report holding 8 issues of IQVIA’s debt, $2.31B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 5.79%, maturing 2026 to 2033.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do IQVIA and its peers compare on margins and cash generation over ten years?”
- “Where did five years of IQVIA's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in IQVIA's last four quarterly filings that the numbers alone won't show?”